"Rosaniline Dyes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that contain the triphenylmethane aniline structure found in rosaniline. Many of them have a characteristic magenta color and are used as COLORING AGENTS.
| Descriptor ID |
D012394
|
| MeSH Number(s) |
D02.092.146.755
|
| Concept/Terms |
Rosaniline Dyes- Rosaniline Dyes
- Dyes, Rosaniline
- Triphenylmethane Aniline Compounds
- Aniline Compounds, Triphenylmethane
- Compounds, Triphenylmethane Aniline
- Magentas
- Fuchsin
- Fuchsins
|
Below are MeSH descriptors whose meaning is more general than "Rosaniline Dyes".
Below are MeSH descriptors whose meaning is more specific than "Rosaniline Dyes".
This graph shows the total number of publications written about "Rosaniline Dyes" by people in this website by year, and whether "Rosaniline Dyes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1998 | 0 | 2 | 2 |
| 1999 | 2 | 1 | 3 |
| 2000 | 0 | 1 | 1 |
| 2001 | 4 | 3 | 7 |
| 2002 | 1 | 1 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 3 | 5 | 8 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 2 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 1 | 2 |
| 2014 | 1 | 1 | 2 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Rosaniline Dyes" by people in Profiles.
-
Remotely Delivered Cancer Genetic Testing in the Making Genetic Testing Accessible (MAGENTA) Trial: A Randomized Clinical Trial. JAMA Oncol. 2023 11 01; 9(11):1547-1555.
-
SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer. Ann Surg Oncol. 2019 Oct; 26(11):3510-3516.
-
Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. Lancet Oncol. 2018 10; 19(10):1394-1403.
-
Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast?Cancer. Clin Breast Cancer. 2018 02; 18(1):e73-e77.
-
Axillary reverse mapping: five-year experience. Surgery. 2014 Nov; 156(5):1261-8.
-
Synthetic circuit for exact adaptation and fold-change detection. Nucleic Acids Res. 2014 May; 42(9):6078-89.
-
A case of green blood. Clin Chem. 2014 Apr; 60(4):695-6.
-
Does blue dye contribute to success of sentinel node mapping for breast cancer? Ann Surg Oncol. 2010 Oct; 17 Suppl 3:280-5.
-
Rectal mucosal quantitative galactose oxidase-Schiff reaction as an early detection biomarker for colorectal cancer: comparison to fecal occult stool blood test. Cancer Biomark. 2010-2011; 8(2):109-12.
-
Engineered 5S ribosomal RNAs displaying aptamers recognizing vascular endothelial growth factor and malachite green. J Mol Recognit. 2009 Mar-Apr; 22(2):154-61.